NCT01860482View on ClinicalTrials.gov

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Reflux Esophagitis
Interventions
DRUG

Newrabell® Tablet 10mg

Trial Locations (2)

501-757

Chonnam National University Hospital, Gwangju

519-763

Chonnam National University Hwasun Hospital, Gwangju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01860482 - The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD | Biotech Hunter | Biotech Hunter